We served as lead counsel for King Pharmaceuticals, Inc. and its board of directors in shareholder class actions relating to the $3.6 billion buyout of King by Pfizer, Inc.
King Pharmaceuticals (NYSE: KG) is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world’s 39th largest pharmaceutical company.
We served as lead counsel for King Pharmaceuticals, Inc. and its board of directors in shareholder class actions relating to the $3.6 billion buyout of King by Pfizer, Inc.
King Pharmaceuticals (NYSE: KG) is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world’s 39th largest pharmaceutical company.